Immuno-PET of epithelial ovarian cancer: harnessing the potential of CA125 for non-invasive imaging

Current Approaches and Challenges in Managing and Monitoring Treatment Response in Ovarian Cancer

(2014) Charlotte S Marcus et al.   Journal of Cancer

Applying PET to Broaden the Diagnostic Utility of the Clinically Validated CA19.9 Serum Biomarker for Oncology

(2013) N. T. Viola-Villegas et al.   JOURNAL OF NUCLEAR MEDICINE

New insights into ovarian cancer pathology

(2012) J. Prat   ANNALS OF ONCOLOGY

A semi-automated system for the routine production of copper-64

(2012) Maiko Kume et al.   APPLIED RADIATION AND ISOTOPES

Comparison of 64Cu-Complexing Bifunctional Chelators for Radioimmunoconjugation: Labeling Efficiency, Specific Activity, and in Vitro/in Vivo Stability

(2012) Maggie S. Cooper et al.   BIOCONJUGATE CHEMISTRY

Follow-up with CA125 after primary therapy of advanced ovarian cancer: in favor of continuing to prescribe CA125 during follow-up

(2011) S. Pignata et al.   ANNALS OF ONCOLOGY

Role of FDG PET/CT in Staging of Recurrent Ovarian Cancer

(2011) Hongju Son et al.   RADIOGRAPHICS

The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect

(2010) Jun Fang et al.   ADVANCED DRUG DELIVERY REVIEWS

89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo

(2010) J. P. Holland et al.   JOURNAL OF NUCLEAR MEDICINE

Imaging cancer using PET — the effect of the bifunctional chelator on the biodistribution of a 64Cu-labeled antibody

(2010) Jason L.J. Dearling et al.   NUCLEAR MEDICINE AND BIOLOGY

Surveillance of patients after initial treatment of ovarian cancer

(2009) Angiolo Gadducci et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

In Vivo Biodistribution, PET Imaging, and Tumor Accumulation of 86Y- and 111In-Antimindin/RG-1, Engineered Antibody Fragments in LNCaP Tumor-Bearing Nude Mice

(2009) D. W. Schneider et al.   JOURNAL OF NUCLEAR MEDICINE